查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
肺癌手術的全球市場 - 產業趨勢與預測(～2029年)
市場調查報告書
商品編碼
1145419

肺癌手術的全球市場 - 產業趨勢與預測(～2029年)

Global Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
出版日期: | 出版商: Data Bridge Market Research | 英文 186 Pages | 商品交期: 請詢問到貨日

價格

全球肺癌手術的市場規模，預計2022年～2029年的預測期間記錄5.5％相當的年複合成長率。

推動全球肺癌手術市場成長的主要原因，是肺癌盛行率增加，醫療領域的技術進步，手術的優點相關認識擴大，大氣污染的擴大和抽煙的劇增。

本報告提供全球肺癌手術市場調查，市場促進因素和阻礙因素，機會和課題，各市場區隔、地區的市場明細，競爭情形，主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

  • PESTEL分析
  • 波特的五力分析

第5章 流行病學

  • 肺癌的發病率:各國
  • 治療率:性別
  • 死亡率:性別

第6章 全球肺癌手術市場法規

第7章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第8章 全球肺癌手術市場:各產品類型

  • 概要
  • 手術器具
    • 手動器具
    • 電動手術設備
  • 監測、可視化系統
    • 相機、影音支援
    • 支氣管鏡
    • 附光學視覺內視鏡穿刺套管
    • 胸腔鏡子
    • 縱隔鏡子
    • 其他
  • 內臟外科用設備
  • 機器人支援手術系統
  • 其他

第9章 全球肺癌手術市場:各外科手術

  • 概要
  • 開胸術
    • 肺葉切除術
    • 袖切除術
    • 區域切除術
    • 肺切除術
    • 其他
  • 微創手術
    • 影音支援胸部手術(VATS)
    • 機器人支援胸部手術(RATS)

第10章 全球肺癌手術市場:各患者類型

  • 概要
  • 男性
    • 老年人
    • 大人
    • 兒童
  • 女性
    • 老年人
    • 大人
    • 兒童

第11章 全球肺癌手術市場:各流通管道

  • 概要
  • 直接競標
  • 零售
  • 線上銷售
  • 其他

第12章 全球肺癌手術市場:各終端用戶

  • 概要
  • 醫院
    • 公立醫院
    • 私立醫院
  • 門診病人手術中心
  • 癌症專門治療中心
  • 學術研究機關
  • 其他

第13章 全球肺癌手術市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 比利時
    • 荷蘭
    • 瑞士
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 菲律賓
    • 其他亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他南美
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 以色列
    • 埃及
    • 其他中東、非洲

第14章 全球肺癌手術市場:企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第15章 SWOT分析

第16章 企業簡介

  • JOHNSON & JOHNSON SERVICES, INC.
  • ACCURAY INCORPORATED
  • INTUITIVE SURGICAL
  • FUJIFILM HOLDINGS CORPORATION
  • AMBU A/S.
  • ANGIODYNAMICS
  • ACKERMANN
  • ASAP ENDOSCOPIC PRODUCTS GMBH
  • FUSIONKRAFT
  • GERMED USA
  • KLS MARTIN GROUP
  • KARL STORZ SE & CO. KG
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
  • MEDTRONICS (2021)
  • OLYMPUS CORPORATION
  • RICHARD WOLF GMBH.
  • SURGICAL HOLDINGS
  • SONTEC INSTRUMENTS, INC.
  • SCANLAN INTERNATIONAL
  • TELEFLEX INCORPORATED
  • TROKAMED GMBH.
  • WEXLER SURGICAL

第17章 問卷調查

第18章 相關報告

Global lung cancer surgery market is projected to register a substantial CAGR of 5.5 % in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:

Global Lung Cancer Surgery Market, By Product Type (Surgical Instruments, Monitoring & Visualising systems Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems and Others), Surgical Procedure (Thoracotomy, Minimally Invasive Surgeries and others), Patient Type (Male and Female), End user, (Hospitals ,Ambulatory Surgical Centers, Academic & Research Laboratories , Specialty Cancer Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales and Others) Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Switzerland, Netherlands, Belgium, Ireland, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Australia, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt and Rest of Middle East and Africa), Industry Trends & Forecast to 2029.

Some of the major factors contributing to the growth of the Global lung cancer surgery market are:

  • Increased prevalence of lung cancer disease
  • Technological advancements in the field of healthcare
  • Increased awareness regarding the benefits.
  • Rise in air pollution and surge in smoking

Market Players:

The key market players for Global lung cancer surgery market are listed below:

  • AngioDynamics
  • Olympus Corporation
  • Johnson & Johnson Services, Inc
  • Ambu A/S.
  • FUJIFILM Holdings Corporation
  • Accuray Incorporated
  • Teleflex Incorporated,
  • KARL STORZ SE & Co. KG,
  • Others

TABLE OF CONTENTS

1 INTRODUCTION 18

  • 1.1 OBJECTIVES OF THE STUDY 18
  • 1.2 MARKET DEFINITION 18
  • 1.3 OVERVIEW OF THE GLOBAL LUNG CANCER SURGERY MARKET 18
  • 1.4 LIMITATIONS 20
  • 1.5 MARKETS COVERED 20

2 MARKET SEGMENTATION 24

  • 2.1 MARKETS COVERED 24
  • 2.2 GEOGRAPHIC SCOPE 25
  • 2.3 YEARS CONSIDERED FOR THE STUDY 26
  • 2.4 CURRENCY AND PRICING 26
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 27
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 30
  • 2.7 MULTIVARIATE MODELLING 31
  • 2.8 PRODUCT TYPE LIFELINE CURVE 31
  • 2.9 DBMR MARKET POSITION GRID 32
  • 2.10 VENDOR SHARE ANALYSIS 34
  • 2.11 MARKET APPLICATION COVERAGE GRID 35
  • 2.12 SECONDARY SOURCES 36
  • 2.13 ASSUMPTIONS 36

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 40

  • 4.1 PESTEL 43
  • 4.2 PORTER'S FIVE FORCES MODEL 44

5 EPIDEMIOLOGY 45

  • 5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY 47
  • 5.2 TREATMENT RATE BY GENDER 48
  • 5.3 MORTALITY BY GENDER 49

6 REGULATIONS OF THE GLOBAL LUNG CANCER SURGERY MARKET 50

7 MARKET OVERVIEW 53

  • 7.1 DRIVERS 55
    • 7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES 55
    • 7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE 55
    • 7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS 55
    • 7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES 56
    • 7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING 56
  • 7.2 RESTRAINTS 57
    • 7.2.1 HIGH COST OF LUNG CANCER SURGERY 57
    • 7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS 57
    • 7.2.3 STRINGENT REGULATORY FRAMEWORKS 57
  • 7.3 OPPORTUNITIES 59
    • 7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY 59
    • 7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 59
    • 7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY 60
  • 7.4 CHALLENGES 60
    • 7.4.1 DEARTH OF SKILLED ONCOLOGISTS 60
    • 7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES 60

8 GLOBAL LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE 62

  • 8.1 OVERVIEW 63
  • 8.2 SURGICAL INSTRUMENTS 66
    • 8.2.1 HAND INSTRUMENTS 67
      • 8.2.1.1 STAPLER 68
      • 8.2.1.2 FORCEPS 68
      • 8.2.1.3 ELECTRIC HOOK 68
      • 8.2.1.4 RETRACTORS 68
      • 8.2.1.5 CLAMPS 68
      • 8.2.1.6 SCISSORS 68
      • 8.2.1.7 ELEVATORS 68
      • 8.2.1.8 HEMOCLIP APPLIERS 69
      • 8.2.1.9 ULTRASOUND SCALPEL 69
      • 8.2.1.10 RIB SHEARS 69
      • 8.2.1.11 CUTTERS 69
      • 8.2.1.12 NEEDLE HOLDER 69
      • 8.2.1.13 TROCAR 69
      • 8.2.1.14 OTHERS 69
    • 8.2.2 POWERED SURGICAL EQUIPMENT 69
      • 8.2.2.1 ADVANCED ENERGY INSTRUMENTS 70
        • 8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS 70
        • 8.2.2.1.2 OTHERS 70
      • 8.2.2.2 BASIC ENERGY INSTRUMENTS 70
        • 8.2.2.2.1 BIPOLAR INSTRUMENTS 71
        • 8.2.2.2.2 MONOPOLAR INSTRUMENTS 71
  • 8.3 MONITORING & VISUALISING SYSTEM 71
    • 8.3.1 CAMERAS & VIDEO SUPPORT 72
    • 8.3.2 BRONCHOSCOPES 72
    • 8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS 72
    • 8.3.4 THORACOSCOPES 72
    • 8.3.5 MEDIASTINOSCOPES 73
    • 8.3.6 OTHERS 73
  • 8.4 ENDOSURGICAL EQUIPMENTS 73
  • 8.5 ROBOTIC ASSISTED SURGERY SYSTEMS 74
  • 8.6 OTHERS 74

9 GLOBAL LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE 75

  • 9.1 OVERVIEW 76
  • 9.2 THORACOTOMY 79
    • 9.2.1 LOBECTOMY 80
      • 9.2.1.1 SURGICAL INSTRUMENTS 80
      • 9.2.1.2 MONITORING & VISUALISING SYSTEMS 80
      • 9.2.1.3 ENDOSURGICAL EQUIPMENT 80
      • 9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 80
      • 9.2.1.5 OTHERS 80
    • 9.2.2 SLEEVE RESECTION 81
      • 9.2.2.1 SURGICAL INSTRUMENTS 81
      • 9.2.2.2 MONITORING & VISUALISING SYSTEMS 81
      • 9.2.2.3 ENDOSURGICAL EQUIPMENT 81
      • 9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 81
      • 9.2.2.5 OTHERS 81
    • 9.2.3 SEGMENTECTOMY 82
      • 9.2.3.1 SURGICAL INSTRUMENTS 82
      • 9.2.3.2 MONITORING & VISUALISING SYSTEMS 82
      • 9.2.3.3 ENDOSURGICAL EQUIPMENT 82
      • 9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 82
      • 9.2.3.5 OTHERS 82
    • 9.2.4 PNEUMONECTOMY 83
      • 9.2.4.1 SURGICAL INSTRUMENTS 83
      • 9.2.4.2 MONITORING & VISUALISING SYSTEMS 83
      • 9.2.4.3 ENDOSURGICAL EQUIPMENT 83
      • 9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 83
      • 9.2.4.5 OTHERS 83
    • 9.2.5 OTHERS 84
  • 9.3 MINIMALLY INVASIVE SURGERIES 84
    • 9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS) 84
      • 9.3.1.1 SURGICAL INSTRUMENTS 85
      • 9.3.1.2 MONITORING & VISUALISING SYSTEMS 85
      • 9.3.1.3 ENDOSURGICAL EQUIPMENT 85
      • 9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 85
      • 9.3.1.5 OTHERS 85
    • 9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) 85
      • 9.3.2.1 SURGICAL INSTRUMENTS 86
      • 9.3.2.2 MONITORING & VISUALISING SYSTEMS 86
      • 9.3.2.3 ENDOSURGICAL EQUIPMENT 86
      • 9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 86
      • 9.3.2.5 OTHERS 86

10 GLOBAL LUNG CANCER SURGERY MARKET, BY PATIENT TYPE 87

  • 10.1 OVERVIEW 88
  • 10.2 MALE 91
    • 10.2.1 GERIATRIC 92
      • 10.2.1.1 THORACOTOMY 92
      • 10.2.1.2 MINIMALLY INVASIVE SURGERIES 92
    • 10.2.2 ADULTS 92
      • 10.2.2.1 THORACOTOMY 93
      • 10.2.2.2 MINIMALLY INVASIVE SURGERIES 93
    • 10.2.3 PEDIATRIC 93
      • 10.2.3.1 THORACOTOMY 93
      • 10.2.3.2 MINIMALLY INVASIVE SURGERIES 93
  • 10.3 FEMALE 94
    • 10.3.1 GERIATRIC 95
      • 10.3.1.1 THORACOTOMY 95
      • 10.3.1.2 MINIMALLY INVASIVE SURGERIES 95
    • 10.3.2 ADULTS 95
      • 10.3.2.1 THORACOTOMY 96
      • 10.3.2.2 MINIMALLY INVASIVE SURGERIES 96
    • 10.3.3 PEDIATRIC 96
      • 10.3.3.1 THORACOTOMY 96
      • 10.3.3.2 MINIMALLY INVASIVE SURGERIES 96

11 GLOBAL LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL 97

  • 11.1 OVERVIEW 98
  • 11.2 DIRECT TENDER 101
  • 11.3 RETAIL SALES 101
  • 11.4 ONLINE SALES 102
  • 11.5 OTHERS 102

12 GLOBAL LUNG CANCER SURGERY MARKET, BY END USER 103

  • 12.1 OVERVIEW 104
  • 12.2 HOSPITALS 107
    • 12.2.1 PUBLIC HOSPITALS 107
    • 12.2.2 PRIVATE HOSPITALS 107
  • 12.3 AMBULATORY SURGICAL CENTERS 108
  • 12.4 SPECIALTY CANCER CARE CENTERS 108
  • 12.5 ACADEMIC AND RESEARCH LABORATORIES 109
  • 12.6 OTHERS 109

13 GLOBAL LUNG CANCER SURGERY MARKET, BY REGION 110

  • 13.1 OVERVIEW 111
  • 13.2 NORTH AMERICA 116
    • 13.2.1 U.S 120
    • 13.2.2 CANADA 120
    • 13.2.3 MEXICO 120
  • 13.3 EUROPE 121
    • 13.3.1 GERMANY 125
    • 13.3.2 FRANCE 125
    • 13.3.3 U.K. 125
    • 13.3.4 ITALY 125
    • 13.3.5 SPAIN 125
    • 13.3.6 RUSSIA 125
    • 13.3.7 TURKEY 125
    • 13.3.8 BELGIUM 126
    • 13.3.9 NETHERLANDS 126
    • 13.3.10 SWITZERLAND 126
    • 13.3.11 REST OF EUROPE 126
  • 13.4 ASIA-PACIFIC 127
    • 13.4.1 CHINA 131
    • 13.4.2 JAPAN 131
    • 13.4.3 INDIA 131
    • 13.4.4 SOUTH KOREA 131
    • 13.4.5 AUSTRALIA 131
    • 13.4.6 SINGAPORE 131
    • 13.4.7 THAILAND 132
    • 13.4.8 MALAYSIA 132
    • 13.4.9 INDONESIA 132
    • 13.4.10 PHILIPPINES 132
    • 13.4.11 REST OF ASIA-PACIFIC 132
  • 13.5 SOUTH AMERICA 133
    • 13.5.1 BRAZIL 137
    • 13.5.2 ARGENTINA 137
    • 13.5.3 REST OF SOUTH AMERICA 137
  • 13.6 MIDDLE EAST AND AFRICA 137
    • 13.6.1 SAUDI ARABIA 142
    • 13.6.2 SOUTH AFRICA 142
    • 13.6.3 UAE 142
    • 13.6.4 ISRAEL 142
    • 13.6.5 EGYPT 142
    • 13.6.6 REST OF MIDDLE EAST AND AFRICA 142

14 GLOBAL LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE 143

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL 143
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 144
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE 145
  • 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 146

15 SWOT ANALYSIS 147

16 COMPANY PROFILES 148

  • 16.1 JOHNSON & JOHNSON SERVICES, INC. 148
    • 16.1.1 COMPANY SNAPSHOT 148
    • 16.1.2 REVENUE ANALYSIS 148
    • 16.1.3 COMPANY SHARE ANALYSIS 149
    • 16.1.4 PRODUCT PORTFOLIO 149
    • 16.1.5 RECENT DEVELOPMENTS 149
  • 16.2 ACCURAY INCORPORATED 151
    • 16.2.1 COMPANY SNAPSHOT 151
    • 16.2.2 REVENUE ANALYSIS 151
    • 16.2.3 COMPANY SHARE ANALYSIS 152
    • 16.2.4 PRODUCT PORTFOLIO 152
    • 16.2.5 RECENT DEVELOPMENTS 152
  • 16.3 INTUITIVE SURGICAL 153
    • 16.3.1 COMPANY SNAPSHOT 153
    • 16.3.2 REVENUE ANALYSIS 153
    • 16.3.3 COMPANY SHARE ANALYSIS 154
    • 16.3.4 PRODUCT PORTFOLIO 154
    • 16.3.5 RECENT DEVELOPMENTS 154
  • 16.4 FUJIFILM HOLDINGS CORPORATION 155
    • 16.4.1 COMPANY SNAPSHOT 155
    • 16.4.2 REVENUE ANALYSIS 155
    • 16.4.3 COMPANY SHARE ANALYSIS 156
    • 16.4.4 PRODUCT PORTFOLIO 156
    • 16.4.5 RECENT DEVELOPMENTS 156
  • 16.5 AMBU A/S. 158
    • 16.5.1 COMPANY SNAPSHOT 158
    • 16.5.2 REVENUE ANALYSIS 158
    • 16.5.3 COMPANY SHARE ANALYSIS 159
    • 16.5.4 PRODUCT PORTFOLIO 159
    • 16.5.5 RECENT DEVELOPMENTS 159
  • 16.6 ANGIODYNAMICS 160
    • 16.6.1 COMPANY SNAPSHOT 160
    • 16.6.2 REVENUE ANALYSIS 160
    • 16.6.3 PRODUCT PORTFOLIO 161
    • 16.6.4 RECENT DEVELOPMENT 161
  • 16.7 ACKERMANN 162
    • 16.7.1 COMPANY SNAPSHOT 162
    • 16.7.2 PRODUCT PORTFOLIO 162
    • 16.7.3 RECENT DEVELOPMENTS 162
  • 16.8 ASAP ENDOSCOPIC PRODUCTS GMBH 163
    • 16.8.1 COMPANY SNAPSHOT 163
    • 16.8.2 PRODUCTPORTFOLIO 163
    • 16.8.3 RECENT DEVELOPMENT 163
  • 16.9 FUSIONKRAFT 164
    • 16.9.1 COMPANY SNAPSHOT 164
    • 16.9.2 PRODUCT PORTFOLIO 164
    • 16.9.3 RECENT DEVELOPMENTS 164
  • 16.10 GERMED USA 165
    • 16.10.1 COMPANY SNAPSHOT 165
    • 16.10.2 PRODUCT PORTFOLIO 165
    • 16.10.3 RECENT DEVELOPMENTS 165
  • 16.11 KLS MARTIN GROUP 166
    • 16.11.1 COMPANY SNAPSHOT 166
    • 16.11.2 PRODUCT PORTFOLIO 166
    • 16.11.3 RECENT DEVELOPMENTS 166
  • 16.12 KARL STORZ SE & CO. KG 167
    • 16.12.1 COMPANY SNAPSHOT 167
    • 16.12.2 PRODUCT PORTFOLIO 167
    • 16.12.3 RECENT DEVELOPMENT 167
  • 16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 168
    • 16.13.1 COMPANY SNAPSHOT 168
    • 16.13.2 PRODUCT PORTFOLIO 168
    • 16.13.3 RECENT DEVELOPMENT 169
  • 16.14 MEDTRONICS (2021) 170
    • 16.14.1 COMPANY SNAPSHOT 170
    • 16.14.2 REVENUE ANALYSIS 170
    • 16.14.3 PRODUCT PORTFOLIO 171
    • 16.14.4 RECENT DEVELOPMENT 171
  • 16.15 OLYMPUS CORPORATION 172
    • 16.15.1 COMPANY SNAPSHOT 172
    • 16.15.2 REVENUE ANALYSIS 172
    • 16.15.3 PRODUCTPORTFOLIO 173
    • 16.15.4 RECENT DEVELOPMENTS 173
  • 16.16 RICHARD WOLF GMBH. 174
    • 16.16.1 COMPANY SNAPSHOT 174
    • 16.16.2 PRODUCT PORTFOLIO 174
    • 16.16.3 RECENT DEVELOPMENTS 174
  • 16.17 SURGICAL HOLDINGS 175
    • 16.17.1 COMPANY SNAPSHOT 175
    • 16.17.2 PRODUCT PORTFOLIO 175
    • 16.17.3 RECENT DEVELOPMENTS 175
  • 16.18 SONTEC INSTRUMENTS, INC. 176
    • 16.18.1 COMPANY SNAPSHOT 176
    • 16.18.2 PRODUCT PORTFOLIO 176
    • 16.18.3 RECENT DEVELOPMENT 176
  • 16.19 SCANLAN INTERNATIONAL 177
    • 16.19.1 COMPANY SNAPSHOT 177
    • 16.19.2 PRODUCT PORTFOLIO 177
    • 16.19.3 RECENT DEVELOPMENTS 177
  • 16.20 TELEFLEX INCORPORATED 178
    • 16.20.1 COMPANY SNAPSHOT 178
    • 16.20.2 REVENUE ANALYSIS 178
    • 16.20.3 PRODUCTPORTFOLIO 179
    • 16.20.4 RECENT DEVELOPMENT 179
  • 16.21 TROKAMED GMBH. 180
    • 16.21.1 COMPANY SNAPSHOT 180
    • 16.21.2 PRODUCT PORTFOLIO 180
    • 16.21.3 RECENT DEVELOPMENT 180
  • 16.22 WEXLER SURGICAL 181
    • 16.22.1 COMPANY SNAPSHOT 181
    • 16.22.2 PRODUCT PORTFOLIO 181
    • 16.22.3 RECENT DEVELOPMENTS 181

17 QUESTIONNAIRE 182

18 RELATED REPORTS 186

LIST OF FIGURES

  • FIGURE 1 GLOBAL LUNG CANCER SURGERYMARKET: SEGMENTATION 24
  • FIGURE 2 GLOBAL LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE 25
  • FIGURE 3 GLOBAL LUNG CANCER SURGERYMARKET: DATA TRIANGULATION 27
  • FIGURE 4 GLOBAL LUNG CANCER SURGERY MARKET: SNAPSHOT 28
  • FIGURE 5 GLOBAL LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH 29
  • FIGURE 6 GLOBAL LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH 29
  • FIGURE 7 GLOBAL LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION 30
  • FIGURE 8 GLOBAL LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID 32
  • FIGURE 9 GLOBAL LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS 34
  • FIGURE 10 GLOBAL LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID 35
  • FIGURE 11 GLOBAL LUNG CANCER SURGERY MARKET SEGMENTATION 39
  • FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE GLOBAL LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029 40
  • FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LUNG CANCER SURGERY MARKET IN 2022 & 2029 40
  • FIGURE 14 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE LUNG CANCER SURGERY MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH A STRONG CAGR IN THE FORECAST PERIOD FROM 2022 TO 2029 41
  • FIGURE 15 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKET FOR THE GLOBAL LUNG CANCER SURGERY MARKET IN THE FORECAST PERIOD FROM 2022 TO 2029 42
  • FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL LUNG CANCER SURGERY MARKET 54
  • FIGURE 17 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021 63
  • FIGURE 18 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION) 64
  • FIGURE 19 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029) 64
  • FIGURE 20 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE 65
  • FIGURE 21 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021 76
  • FIGURE 22 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION) 77
  • FIGURE 23 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029) 77
  • FIGURE 24 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE 78
  • FIGURE 25 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021 88
  • FIGURE 26 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION) 89
  • FIGURE 27 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029) 89
  • FIGURE 28 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE 90
  • FIGURE 29 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021 98
  • FIGURE 30 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 99
  • FIGURE 31 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 99
  • FIGURE 32 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 100
  • FIGURE 33 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, 2021 104
  • FIGURE 34 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION) 105
  • FIGURE 35 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029) 105
  • FIGURE 36 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE 106
  • FIGURE 37 GLOBAL LUNG CANCER SURGERY MARKET: SNAPSHOT (2021) 112
  • FIGURE 38 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2021) 113
  • FIGURE 39 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2022 & 2029) 113
  • FIGURE 40 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2021 & 2029) 114
  • FIGURE 41 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029) 114
  • FIGURE 42 NORTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021) 117
  • FIGURE 43 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021) 118
  • FIGURE 44 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029) 118
  • FIGURE 45 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029) 119
  • FIGURE 46 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029) 119
  • FIGURE 47 EUROPE LUNG CANCER SURGERY MARKET: SNAPSHOT (2021) 122
  • FIGURE 48 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021) 123
  • FIGURE 49 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029) 123
  • FIGURE 50 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029) 124
  • FIGURE 51 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029) 124
  • FIGURE 52 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: SNAPSHOT (2021) 128
  • FIGURE 53 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021) 129
  • FIGURE 54 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029) 129
  • FIGURE 55 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029) 130
  • FIGURE 56 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029) 130
  • FIGURE 57 SOUTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021) 134
  • FIGURE 58 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021) 135
  • FIGURE 59 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029) 135
  • FIGURE 60 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029) 136
  • FIGURE 61 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029) 136
  • FIGURE 62 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021) 139
  • FIGURE 63 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021) 140
  • FIGURE 64 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029) 140
  • FIGURE 65 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029) 141
  • FIGURE 66 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029) 141
  • FIGURE 67 GLOBAL LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%) 143
  • FIGURE 68 NORTH AMERICA LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%) 144
  • FIGURE 69 EUROPE LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%) 145
  • FIGURE 70 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%) 146